-
1
-
2
-
3
-
4
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
Published 2025-01-01Subjects: Get full text
Article -
5
Complete remission in an advanced hepatocellular carcinoma patient with AXIN1 mutation after systemic therapy: A case report
Published 2025-01-01Subjects: Get full text
Article -
6
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
Published 2024-11-01Subjects: “…Hepatic arterial infusion chemotherapy…”
Get full text
Article -
7
The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
Published 2025-02-01Subjects: “…drug-eluting beads-transarterial chemoembolization-hepatic arterial infusion chemotherapy…”
Get full text
Article -
8
Single‐Nucleus and Spatial Transcriptome Profiling Delineates the Multicellular Ecosystem in Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
Published 2025-02-01Subjects: “…hepatic arterial infusion chemotherapy…”
Get full text
Article -
9
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
Published 2025-02-01Subjects: “…hepatic arterial infusion chemotherapy (HAIC)…”
Get full text
Article